FDA Approved: AMPHETAMINE SULFATE — Original Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Granules Pharmaceuticals Inc.'s amphetamine sulfate as an Original Application under the ANDA212619, marking a generic product approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• Amphetamine sulfate (amphetamine sulfate)

Snippet

ORIG AP for AMPHETAMINE SULFATE (AMPHETAMINE SULFATE)